Rori Salvaggio

549 total citations
13 papers, 387 citations indexed

About

Rori Salvaggio is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Cancer Research. According to data from OpenAlex, Rori Salvaggio has authored 13 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 4 papers in Public Health, Environmental and Occupational Health and 3 papers in Cancer Research. Recurrent topics in Rori Salvaggio's work include Cancer survivorship and care (8 papers), Cancer Treatment and Pharmacology (5 papers) and Neutropenia and Cancer Infections (3 papers). Rori Salvaggio is often cited by papers focused on Cancer survivorship and care (8 papers), Cancer Treatment and Pharmacology (5 papers) and Neutropenia and Cancer Infections (3 papers). Rori Salvaggio collaborates with scholars based in United States. Rori Salvaggio's co-authors include Larry Norton, Andrew D. Seidman, Clifford A. Hudis, Theresa Gilewski, Violante E. Currie, Mary Ellen Moynahan, Louis‐Joseph Auguste, José Baselga, David R. Spriggs and Prudence A. Francis and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and JAMA Network Open.

In The Last Decade

Rori Salvaggio

12 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rori Salvaggio United States	7	304	95	76	66	35	13	387
Diana T. Chingos United States	8	278 0.9×	110 1.2×	117 1.5×	88 1.3×	58 1.7×	8	516
Marjan van Hezewijk Netherlands	10	169 0.6×	69 0.7×	38 0.5×	43 0.7×	24 0.7×	20	271
Jennifer Westrup United States	7	268 0.9×	177 1.9×	97 1.3×	53 0.8×	65 1.9×	12	562
Oliver Higuera Spain	13	305 1.0×	61 0.6×	135 1.8×	54 0.8×	30 0.9×	40	480
Lisa M. Moy United States	11	158 0.5×	55 0.6×	84 1.1×	31 0.5×	27 0.8×	18	329
Suzana Sales de Aguiar Brazil	15	369 1.2×	105 1.1×	55 0.7×	172 2.6×	33 0.9×	36	567
Yvonne Zissiadis Australia	13	309 1.0×	91 1.0×	68 0.9×	61 0.9×	96 2.7×	29	509
Rebecca Smittenaar United Kingdom	6	237 0.8×	48 0.5×	76 1.0×	49 0.7×	26 0.7×	14	377
P. N. Jeal Australia	4	318 1.0×	99 1.0×	77 1.0×	60 0.9×	75 2.1×	5	437
Daniel S. O’Neil United States	13	230 0.8×	37 0.4×	35 0.5×	68 1.0×	21 0.6×	38	401

Countries citing papers authored by Rori Salvaggio

Since Specialization

Citations

This map shows the geographic impact of Rori Salvaggio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rori Salvaggio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rori Salvaggio more than expected).

Fields of papers citing papers by Rori Salvaggio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rori Salvaggio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rori Salvaggio. The network helps show where Rori Salvaggio may publish in the future.

Co-authorship network of co-authors of Rori Salvaggio

This figure shows the co-authorship network connecting the top 25 collaborators of Rori Salvaggio. A scholar is included among the top collaborators of Rori Salvaggio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rori Salvaggio. Rori Salvaggio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Wilhelm, Clare, Katherine S. Panageas, Jessie C. Holland, et al.. (2024). Oncology Clinicians' Perspectives of a Remote Patient Monitoring Program: Multi-Modal Case Study Approach. JMIR Human Factors. 12. e60585–e60585.

Daly, Bobby, Jennifer R. Cracchiolo, Jessie C. Holland, et al.. (2024). Digitally Enabled Transitional Care Management in Oncology. JCO Oncology Practice. 20(5). 657–665. 5 indexed citations

Daly, Bobby, Jessica Flynn, Katherine S. Panageas, et al.. (2022). Association Between Remote Monitoring and Acute Care Visits in High-Risk Patients Initiating Intravenous Antineoplastic Therapy. JCO Oncology Practice. 18(12). e1935–e1942. 6 indexed citations

Daly, Bobby, Jessica Flynn, Katherine S. Panageas, et al.. (2022). Analysis of a Remote Monitoring Program for Symptoms Among Adults With Cancer Receiving Antineoplastic Therapy. JAMA Network Open. 5(3). e221078–e221078. 42 indexed citations

Cracchiolo, Jennifer R., Michael J. Hannon, Jessie C. Holland, et al.. (2022). Remote symptom monitoring after hospital discharge.. Journal of Clinical Oncology. 40(16_suppl). 1517–1517. 5 indexed citations

Flynn, Jessica, Katherine S. Panageas, Alice Zervoudakis, et al.. (2022). Association between remote monitoring and acute care visits in high-risk patients initiating intravenous antineoplastic therapy.. Journal of Clinical Oncology. 40(16_suppl). 1578–1578. 1 indexed citations

Daly, Bobby, Jessie C. Holland, Chasity Burrows Walters, et al.. (2021). Oncology Patients' Perspectives on Remote Patient Monitoring for COVID-19. JCO Oncology Practice. 17(9). e1278–e1285. 23 indexed citations

Xiao, Han, et al.. (2020). Implementation of Symptom Care Clinic (SCC) for acute symptoms management at outpatient oncology ambulatory centers.. Journal of Clinical Oncology. 38(15_suppl). 2030–2030. 1 indexed citations

Daly, Bobby, Alice Zervoudakis, Lior Gazit, et al.. (2020). Building a Clinically Relevant Risk Model: Predicting Risk of a Potentially Preventable Acute Care Visit for Patients Starting Antineoplastic Treatment. JCO Clinical Cancer Informatics. 4(4). 275–289. 13 indexed citations

10.

Seidman, Andrew D., Maria Theodoulou, Mary Ellen Moynahan, et al.. (2001). Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinoma.. PubMed. 7(12). 3934–41. 25 indexed citations

11.

Hudis, Clifford A., Monica Fornier, David Lebwohl, et al.. (1999). 5-Year Results of Dose-Intensive Sequential Adjuvant Chemotherapy for Women With High-Risk Node-Positive Breast Cancer: A Phase II Study. Journal of Clinical Oncology. 17(4). 1118–1118. 43 indexed citations

12.

Seidman, Andrew D., Daniel Hochhauser, Tzy‐Jyun Yao, et al.. (1996). Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer.. Journal of Clinical Oncology. 14(6). 1877–1884. 138 indexed citations

13.

Seidman, Andrew D., Russell K. Portenoy, T. J. Yao, et al.. (1995). Quality of Life in Phase II Trials: a Study of Methodology and Predictive Value in Patients With Advanced Breast Cancer Treated With Paclitaxel Plus Granulocyte Colony-Stimulating Factor. JNCI Journal of the National Cancer Institute. 87(17). 1316–1322. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact